Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemia

Autor(es)

L.A. Salazar ^[1] ; S.A. Cavalli ^[2] ; M.H. Hirata ^[3] ; J. Diament ^[4] ; N. Forti ^[5] ; S.D. Giannini ^[6] ; E.R. Nakandakare ^[7] ; M.C. Bertolami ^[8] ; R.D.C. Hirata ^[9]

Afiliação do(s) autor(es)

^[1] Universidade de São Paulo. de Ciências Farmacêuticas. Departamento de Análises Clínicas e Toxicológicas

^[2] Universidade de São Paulo. de Ciências Farmacêuticas. Departamento de Análises Clínicas e Toxicológicas

^[3] Universidade de São Paulo. de Ciências Farmacêuticas. Departamento de Análises Clínicas e Toxicológicas

^[4] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[5] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[6] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[7] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas - Brasil

^[8] Instituto Dante Pazzanese de Cardiologia - Brasil

^[9] Universidade de São Paulo. de Ciências Farmacêuticas. Departamento de Análises Clínicas e Toxicológicas

• Tipo de documento: Artigo Científico
• Fonte: Brazilian Journal of Medical and Biological Research; v. 33, n. 11, p. 1301-1304, 2000-11-00.

Resumo

Familial hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma low-density lipoprotein (LDL) level. The disease is caused by several different mutations in the LDL receptor gene. Although early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infarction, the techniques available for determining the number of the functional LDL receptor molecules are difficult to carry out and expensive. Polymorphisms associated with this gene may be used for unequivocal diagnosis of FH in several populations. The aim of our study was to evaluate the genotype distribution and relative allele frequencies of three polymorphisms of the LDL receptor gene, HincII1773 (exon 12), AvaII (exon 13) and PvuII (intron 15), in 50 unrelated Brazilian individuals with a diagnosis of heterozygous FH and in 130 normolipidemic controls. Genomic DNA was extracted from blood leukocytes by a modified salting-out method. The polymorphisms were detected by PCR-RFLP. The FH subjects showed a higher frequency of A+A+ (AvaII), H+H+ (HincII1773) and P1P1 (PvuII) homozygous genotypes when compared to the control group (P<0.05). In addition, FH probands presented a high frequency of A+ (0.58), H+ (0.61) and P1 (0.78) alleles when compared to normolipidemic individuals (0.45, 0.45 and 0.64, respectively). The strong association observed between these alleles and FH suggests that AvaII, HincII1773 and PvuII polymorphisms could be useful to monitor the inheritance of FH in Brazilian families. (AU)

• Processo FAPESP: 98/09759-8 - Análise do polimorfismo genético e expressão do receptor da LDL em indivíduos hipercolesterolêmicos
• Beneficiário: Luis Antonio Salazar Navarrete
• Modalidade de apoio: Bolsas no Brasil - Doutorado